Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effectiveness of a Treatment for Social Cognition Disorders (T-ScEmo) in Patients With Acquired Brain Injury and Comorbid Neuropsychiatric Problems

NCT06923683 is registered in ClinicalTrials.gov with Ggz Oost Brabant as lead sponsor.

NCT NCT06923683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06923683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effectiveness of a Treatment for Social Cognition Disorders (T-ScEmo) in Patients With Acquired Brain Injury and Comorbid Neuropsychiatric Problems
Lead sponsor
Ggz Oost Brabant
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 1, 2025
Completion date
December 31, 2027
Enrollment
8 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acquired brain injury, neuropsychiatric symptoms